Immunologic privilege in the central nervous system and the blood-brain barrier. - Wikidata - awgldk - TriplyDB

Immunologic privilege in the central nervous system and the blood-brain barrier.

Immunologic privilege in the central nervous system and the blood-brain barrier.

http://www.wikidata.org/entity/Q36684162

about

Immune cascades in human intervertebral disc: the pros and cons Redox control of microglial function: molecular mechanisms and functional significance Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology Targeting the Brain Reservoirs: Toward an HIV Cure Cellular Stress Response and Immune Signaling in Retinal Ischemia-Reperfusion Injury The molecular constituents of the blood-brain barrier Banking on iPSC--is it doable and is it worthwhile Soluble Epoxide Hydrolase in Hydrocephalus, Cerebral Edema, and Vascular Inflammation After Subarachnoid Hemorrhage Pregnancy, Labor, and Delivery after Ebola Virus Disease and Implications for Infection Control in Obstetric Services, United States Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation Dealing with Danger in the CNS: The Response of the Immune System to Injury.The detection of surfactant proteins A, B, C and D in the human brain and their regulation in cerebral infarction, autoimmune conditions and infections of the CNS.Gene therapy for metachromatic leukodystrophy.Induction of microglia activation after infection with the non-neurotropic A/CA/04/2009 H1N1 influenza virus.Comparison of the global gene expression of choroid plexus and meninges and associated vasculature under control conditions and after pronounced hyperthermia or amphetamine toxicity Delivery of chemotherapeutics across the blood-brain barrier: challenges and advances.Increased Transendothelial Transport of CCL3 Is Insufficient to Drive Immune Cell Transmigration through the Blood-Brain Barrier under Inflammatory Conditions In Vitro.What causes alopecia areata?Moving stem cells to the clinic: potential and limitations for brain repair Taenia solium: Development of an Experimental Model of Porcine Neurocysticercosis.Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.Outer brain barriers in rat and human development.Stem cells for cell replacement therapy: a therapeutic strategy for HD?Interleukin-1β induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes.Unsanctifying the sanctuary: challenges and opportunities with brain metastases.Prolonged White Matter Inflammation After Cardiopulmonary Bypass and Circulatory Arrest in a Juvenile Porcine Model.Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites HIV-specific CD8⁺ T cells and HIV eradication The extracellular matrix protein laminin-10 promotes blood-brain barrier repair after hypoxia and inflammation in vitro.Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms.Manifestations of immune tolerance in the human female reproductive tract.TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells.Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis Differential virulence and pathogenesis of West Nile viruses.Regulatory landscape and clinical implication of MBD3 in human malignant glioma.Contrasting pediatric and adult cerebral malaria: the role of the endothelial barrier.Blood-brain barrier structure and function and the challenges for CNS drug delivery.Virus infection, antiviral immunity, and autoimmunity.

P2860

Q24625561-5E7929A2-1183-476C-B8C0-6B3F1D21C82D Q27000279-30FAB92B-4C30-4365-AB02-CDF449ECC831 Q27005695-43766DF9-4A10-41FB-842E-1D3EDFCB6510 Q28075694-41562920-D209-4FD3-B7A3-B85ABD3A8F8D Q28079203-143E50DA-8AEB-46C9-B5C4-E2E4CFCA9D82 Q28087222-CB5BE66F-3494-46BC-9EF7-557268771573 Q28254023-1230D022-AA9E-47F0-AEE9-AD83B64D1469 Q28262216-15EFF359-3252-49D3-8685-FA4C5AB8AE12 Q28397600-762EFD8B-DCC0-45F8-84DA-8E39A5C0636E Q28543575-AF67BC86-7127-4C03-9AE2-6657DCA113DF Q30279070-7ED9660C-848D-4D78-9D94-12994EA78230 Q30317702-CE8B1193-BE9E-45F3-8A3D-9B09CBD0D02C Q30357745-FB99D678-CAAF-4DF8-8EA9-9BFF98C0CAD6 Q30373563-1E2C645B-64FD-47E2-8DC4-2B4BE4EA6FFA Q30537801-5696999F-6BA8-4FE3-92B3-3A6970A0DFC6 Q30859319-AFF190F1-BF7C-43BB-9705-B9260800C15D Q33775611-3C388B4A-4CBE-4874-A038-89F9A65E1ABE Q33889367-6C80463F-C248-42CB-AD41-7B8CFBC2E90C Q34470920-E7DD91C9-4A4B-48B4-A0A1-DEE6C34EB8C8 Q34488709-CCC84669-442E-48E5-B2B0-84D0BD81777E Q34657329-F5D69756-04CE-452D-A411-AEF6CD14CC10 Q35034401-73D98C11-6967-402C-AC78-8BF3EAD58BBF Q35179599-EAE8A0B3-4A44-4AE6-A4BE-C8D3EAC9327F Q35250495-19D3A7F3-CB71-4542-AFCC-F7E6E3499DC4 Q35330589-0AFD9E6A-9C56-4600-B163-A7BC4BEDA32B Q35788631-F6FB670F-E050-4361-B88B-7D55E67B022B Q36053181-D6084D69-E873-4C2A-8A97-41A9FBC69374 Q36434294-6DE8CC6F-85B4-42CB-8201-46E414E79355 Q36515071-514D9536-1D91-4ACD-BE7E-89124035C38B Q36530092-A53F679F-BD62-4A83-8D2D-3AF8986C70C6 Q36560327-0D90F071-4AE6-4538-A170-1F4C0BD4D950 Q36606027-23D66D24-5C2D-463E-A749-952D7EA15BD9 Q36825602-ED8AFDAF-D214-4616-9167-635A4EB0C4EA Q36959330-048CBDFE-D79F-414D-9B1B-52F073C2C345 Q37157311-A8443B5B-8D13-41AE-9ED3-5789F797DF97 Q37376398-6535186F-C7F2-4DF0-8CB1-1A95DE36A78E Q37684657-AAE35FBC-BBFE-402D-AC5E-5C255C5FE0F4 Q37713193-BE020EB4-72E4-4E20-8FA1-5EFEF7132456 Q38100970-E6D2A732-8FC4-426D-BAD2-23516CC2BA80 Q38129086-703F2D65-C909-4305-9A5E-57847E0A4B1C

P2860

Immunologic privilege in the central nervous system and the blood-brain barrier.

http://www.wikidata.org/entity/Q36684162

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Immunologic privilege in the central nervous system and the blood-brain barrier.

@ast

Immunologic privilege in the central nervous system and the blood-brain barrier.

@en

type

label

Immunologic privilege in the central nervous system and the blood-brain barrier.

@ast

Immunologic privilege in the central nervous system and the blood-brain barrier.

@en

altLabel

Immunologic Privilege in the Central Nervous System and the Blood–Brain Barrier

@en

prefLabel

Immunologic privilege in the central nervous system and the blood-brain barrier.

@ast

Immunologic privilege in the central nervous system and the blood-brain barrier.

@en

P1433

Q36684162-CEE58364-4B38-4849-AEC4-2F28F8D002FA

P1476

Q36684162-760FBF40-2C3D-4592-8353-7856B4A43621

P2093

Q36684162-0269153B-0B88-4F77-9145-3D09D17C0B4B

Q36684162-11A24DFA-7D99-4ED1-BA71-0C49871797EF

Q36684162-14F6620E-AE39-46D0-B4EE-2CE70731B666

Q36684162-43AE6DFF-F0A7-4E82-825D-E3DE6DCB9F71

Q36684162-592AFB96-7FC7-4C11-8069-5D5C4290AE28

Q36684162-7755BD8B-1DF3-4D5E-81F5-CC3A7AD90968

Q36684162-B5912786-4D94-4BCF-B76D-01EB8B1913E4

Q36684162-BAE8D9E1-36F2-40B0-9344-BE2CF45F17AB

Q36684162-C7366ECF-CFA1-42F6-9219-BBD856DFB7AB

Q36684162-DC7A1B02-DC53-43C2-AC11-F316953744B4

P2860

Q36684162-00645243-5194-412F-8EA2-BF0BBBEEFC7C

Q36684162-0285C94E-5C9B-4305-A6E8-CB8C2A65E139

Q36684162-0525DEBE-F9D1-41F0-A2A0-C0A9AA41351C

Q36684162-0733EE48-B060-4C79-8CDA-1405DE56434E

Q36684162-0906E85F-BE61-4476-81E5-18AC656E0BE8

Q36684162-0C08CF0D-1C24-4BF1-83AA-864AF0C5BFCC

Q36684162-0EAE4EFC-20C8-4C92-9ECE-59E8B212BB12

Q36684162-12B5F8AF-7F7A-49B7-98A1-7491AAA4F2C9

Q36684162-18C7E069-6C73-4B39-9987-496A632D03B8

Q36684162-1B19D384-C15C-4192-B4AD-8D3D3AC71F94

P304

Q36684162-4C4BBA15-83E2-49A4-BC3D-048E5249B633

P31

Q36684162-AE73A22E-85F6-438A-9338-00D5C9FEC35A

P356

Q36684162-59457FD8-1C2C-4DE0-AEA3-6D3FB2BF805F

P433

Q36684162-02852787-7C61-445F-AFAC-EEEB524A9FB1

P478

Q36684162-79BDB790-4618-41CF-B9CD-D99E21559964

P50

Q36684162-190E0A2B-FBC0-44B6-BBBE-D0B8ACCC924C

Q36684162-2B0A02C6-E306-4F08-9B4A-D1901EAFAED5

Q36684162-490FD43C-F409-48EC-BDD0-D77E80781F42

Q36684162-814D043D-FDA1-458B-8B75-A482E1600E5D

P577

Q36684162-11552D76-A172-4128-9F53-95D01CF898D6

P5875

Q36684162-F318C351-8655-47FD-A30D-9B69C763F00E

P698

Q36684162-561A9371-5808-48AD-81A4-C81878D0626E

P921

Q36684162-83AD7F31-C3D2-49B4-918A-549F05E6862E

P932

Q36684162-1C0E3A53-8B0E-4E88-A511-4EBD09DD391F

P356

P1433

Journal of Cerebral Blood Flow & Metabolism

P1476

Immunologic privilege in the central nervous system and the blood-brain barrier.

@en

P2093

Alexandre Prat

http://www.w3.org/2001/XMLSchema#string

David J Begley

http://www.w3.org/2001/XMLSchema#string

Gregory J Del Zoppo

http://www.w3.org/2001/XMLSchema#string

John M Hallenbeck

http://www.w3.org/2001/XMLSchema#string

John R Ohlfest

http://www.w3.org/2001/XMLSchema#string

Jorge I Alvarez

http://www.w3.org/2001/XMLSchema#string

Leslie L Muldoon

http://www.w3.org/2001/XMLSchema#string

Lester R Drewes

http://www.w3.org/2001/XMLSchema#string

Maurizio Scarpa

http://www.w3.org/2001/XMLSchema#string

Nancy D Doolittle

http://www.w3.org/2001/XMLSchema#string

P2860

Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

Blood-brain barrier alterations in ageing and dementia

Paraneoplastic neurological degenerations: keys to tumour immunity

The impact of the extracellular matrix on inflammation

Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease.

Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response

P304

13-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JCBFM.2012.153

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Richard J Smeyne

Britta Engelhardt

Edward A. Neuwelt

P577

2012-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232277157

http://www.w3.org/2001/XMLSchema#string

P698

23072749

http://www.w3.org/2001/XMLSchema#string

P921

blood–brain barrier

P932

3597357

http://www.w3.org/2001/XMLSchema#string